You are here: Industry Insights > cholesterol

News List

Chicken No Better Than Beef for Your Cholesterol? drugs
June 05, 2019
Flying in the face of popular belief, new research suggests both red meat and white meat can drive up your cholesterol levels.
Forget Fasting Before That Cholesterol Test drugs
May 31, 2019
For folks who hate to fast before getting a blood test to check their cholesterol levels, a new study delivers some good news.
High LDL Cholesterol Tied to Early-Onset Alzheimer's drugs
May 30, 2019
High LDL Cholesterol Tied to Early-Onset Alzheimer's.
Cholesterol Levels Improving Among U.S. Kids drugs
May 22, 2019
Cholesterol Levels Improving Among U.S. Kids.
Adding Bempedoic Acid to Statin Therapy Reduces LDL Cholesterol drugs
March 14, 2019
Bempedoic acid, an inhibitor of ATP citrate lyase (ACLY), added to maximally tolerated statin therapy, significantly reduces levels of low-density lipoprotein (LDL) cholesterol in patients with atherosclerotic cardiovascular disease and/or heterozygous fa
New cholesterol-lowering drug could help patients unable to take statins worldpharmanews
March 14, 2019
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects.
Genetic studies: a powerful tool for testing combination therapies pharmaceutical
November 19, 2018
A genetic study by MRC has suggested that combining lipoprotein lipase (LPL) enhancers with cholesterol lowering agents further reduces the risk of heart attacks than cholesterol lowering agents alone.
Amgen slashes price of cholesterol drug Repatha by 60% pharmafile
October 31, 2018
American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%.
Could Too Much 'Good' HDL Cholesterol Be Bad for Your Heart? drugs
August 28, 2018
When it comes to protecting one's heart, high-density lipoprotein cholesterol -- or HDL -- has long had a reputation of being the "good" cholesterol, compared to the "bad" cholesterol -- LDL (low-density lipoprotein).
Sanofi, Regeneron to cut price of Praluent pharmatimes
July 24, 2018
Selina McKee Sanofi and Regeneron have pledged to make Praluent more accessible to patients as data show that the drug significantly cut the risk of cardiovascular events in high-risk patients.

Previous page 1 2 3 4 Next page